← SynDRA
VLX600
SynDRA canonical compound SYN1955286 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | TP53 | USP14 |
| Mechanism of action | antitumor agent | ubiquitin C-terminal hydrolase inhibitor |
All known targets
Mechanisms of action (all sources)
- antitumor agent
- ubiquitin C-terminal hydrolase inhibitor
Cross-references
Synonyms
- GCXMWESEENEVIC-UHFFFAOYSA-N
- 6-methyl-3-(2-(1-(pyridin-2-yl)ethylidene)hydrazinyl)-5H-[1,2,4]triazino[5,6-b]indole
- VLX-600
- YZO6DG19MG
- 6-Methyl-3-((2E)-2-(1-(pyridin-2-yl)ethylidene)hydrazinyl)-5H-(1,2,4)triazino(5,6-b)indole
- Ethanone, 1-(2-pyridinyl)-, 2-(6-methyl-5H-1,2,4-triazino(5,6-b)indol-3-yl)hydrazone
- 6-Methyl-3-((2Z)-2-(1-(2-pyridinyl)ethylidene)hydrazino)-5H-[1,2,4]triazino[5,6-b]indole
- UNII-YZO6DG19MG
- 6-methyl-3-{(2E)-2-[1-(pyridin-2-yl)ethylidene]hydrazinyl}-5H-[1,2,4]triazino[5,6-b]indole
- CHEMBL4788406
- SCHEMBL20518451
- CNA03155
- EX-A3455
- MFCD01305422
- STK791986
- ZINC16671893
- AKOS000354357
- 6-methyl-N-[(E)-1-pyridin-2-ylethylideneamino]-5H-[1,2,4]triazino[5,6-b]indol-3-amine
- AS-79800
- HY-12406
- CS-0011257
- EN300-395210
- Z2694498001
- 2-[1-(2-{6-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl}hydrazin-1-ylidene)ethyl]pyridine
Look up VLX600 in the interactive SynDRA portal →